4.5 Review

Time to reconsider the routine use of tourniquets in total knee arthroplasty surgery AN ABRIDGED VERSION OF A COCHRANE SYSTEMATIC REVIEW AND META-A NALYSIS

Journal

BONE & JOINT JOURNAL
Volume 103B, Issue 5, Pages 830-839

Publisher

BRITISH EDITORIAL SOC BONE & JOINT SURGERY
DOI: 10.1302/0301-620X.103B.BJJ-2020-1926.R1

Keywords

-

Funding

  1. National Institute for Health Research (NIHR) [PDF-2015-08-108]
  2. University of Warwick
  3. National Institutes of Health Research (NIHR) [PDF-2015-08-108] Funding Source: National Institutes of Health Research (NIHR)

Ask authors/readers for more resources

This study included 41 randomized controlled trials with 2,819 participants, and found that TKA with a tourniquet is associated with an increased risk of serious adverse events, higher pain scores, and a slightly longer hospital stay. The only benefit of tourniquet use was a shorter duration of surgery.
Aims Many surgeons choose to perform total knee arthroplasty (TKA) surgery with the aid of a tourniquet. A tourniquet is a device that fits around the leg and restricts blood flow to the limb. There is a need to understand whether tourniquets are safe, and if they benefit, or harm, patients. The aim of this study was to determine the benefits and harms of tourniquet use in TKA surgery. Methods We searched MEDLINE, EMBASE, Cochrane Central Register of Controlled trials, and trial registries up to 26 March 2020. We included randomized controlled trials (RCTs), comparing TKA with a tourniquet versus without a tourniquet. Outcomes included: pain, function, serious adverse events (SAEs), blood loss, implant stability, duration of surgery, and length of hospital stay. Results We included 41 RCTs with 2,819 participants. SAEs were significantly more common in the tourniquet group (53/901 vs 26/898, tourniquet vs no tourniquet respectively) (risk ratio 1.73 (95% confidence interval (CI) 1.10 to 2.73). The mean pain score on the first postoperative day was 1.25 points higher (95% CI 0.32 to 2.19) in the tourniquet group. Overall blood loss did not differ between groups (mean difference 8.61 ml; 95% CI -83.76 to 100.97). The mean length of hospital stay was 0.34 days longer in the group that had surgery with a tourniquet (95% CI 0.03 to 0.64) and the mean duration of surgery was 3.7 minutes shorter (95% CI -5.53 to -1.87). Conclusion TKA with a tourniquet is associated with an increased risk of SAEs, pain, and a marginally longer hospital stay. The only finding in favour of tourniquet use was a shorter time in theatre. The results make it difficult to justify the routine use of a tourniquet in TKA surgery.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available